The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously ...

Determined to make HPV and cervical cancer screenings less invasive, these researchers have turned to menstrual blood.

Neuropathy: Some drugs used to treat cervical cancer, including paclitaxel and cisplatin, can damage nerves outside of the brain and spinal cord. This can sometimes lead to symptoms like numbness, ...

Chinese women aged 65 years or older have significantly higher rates of high-risk human papillomavirus infection and cervical ...

Women 65 and older face significantly higher rates of cervical cancer-causing HPV infections than younger women, despite current medical guidelines that typically discontinue screening at 65. The ...

Women aged 65 and above are still at heightened risk of cervical cancer caused by human papillomavirus (HPV), suggest the findings of a large observational study published in the open access journal ...

Finding cervical cancer often starts with an abnormal HPV (human papillomavirus) or Pap test result. This will lead to further tests which can diagnose cervical cancer or pre-cancer. The Pap test and ...

The Role of Human Papilloma Virus Testing in Cervical Cancer Prevention Molly C. Fey, FNP, MSN; Margaret W. Beal, CNM, PhD Disclosures J Midwifery Womens Health. 2004;49 (1) 0 ...

AI tools achieve high precision in cervical cancer staging and survival prediction The study found that deep learning models, especially CNNs, were the most frequently implemented technique (61.2%), ...

A post hoc analysis of the pivotal phase 3 BEATcc trial (NCT03556839) has revealed that the clinical benefits of adding atezolizumab (Tecentriq) to standard chemotherapy and bevacizumab (Avastin) in ...

"Shocking and really terrifying" - that's how it felt for Alliance Party assembly member Michelle Guy when she was diagnosed with cervical cancer in November 2023. Guy, who was 44 at the time and ...

In an interview with Targeted OncologyTM, Linda Duska, MD, FASCO, MPH, University of Virginia Health, discusses the unmet needs in the cervical cancer space, as well as the rational that prompted the ...